Does the EQ-5D capture the concerns measured by the Palliative care Outcome Scale? Mapping the Palliative care Outcome Scale onto the EQ-5D using statistical methods

Palliative Medicine

Volumn 31, Issue 8, 2017, Pages 716-725

  Dzingina, Mendwas D ^a   McCrone, Paul ^a   Higginson, Irene J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

EQ 5D; health state utility; modelling; palliative care outcome scale; patient reported outcomes

Indexed keywords

AGED; ANXIETY; ARTICLE; CANCER MORTALITY; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DEPRESSION; EQ-5D; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; OBLIMIN ROTATION; OBLIQUE ROTATION; OUTCOME ASSESSMENT; PAIN; PALLIATIVE CARE OUTCOME SCALE; PALLIATIVE THERAPY; PARKINSON DISEASE; PRINCIPAL COMPONENT ANALYSIS; SELF CARE; VALIDATION PROCESS; VARIMAX ROTATION; ENGLAND; MIDDLE AGED; PATIENT-REPORTED OUTCOME; PSYCHOLOGY; QUESTIONNAIRE; STANDARDS; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONDON; MALE; MIDDLE AGED; MODELS, STATISTICAL; PALLIATIVE CARE; PATIENT REPORTED OUTCOME MEASURES; SURVEYS AND QUESTIONNAIRES;

EID: 85027379141     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216317705608     Document Type: Article

References (45)

1. Dzingina MD, Higginson IJ., Public health and palliative care in 2015. Clin Geriatr Med 2015; 31: 253–263.
2. Rowen D, Brazier J, Young T. Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health 2011; 14: 721–731.
3. Sonntag M, Konnopka A, Leichsenring F. Reliability, validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with social phobia. Health Qual Life Outcomes 2013; 11: 215.
4. Hurst NP, Kind P, Ruta D. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Rheumatology 1997; 36: 551–559.
5. Wichmann AB, Adang EM, Stalmeier PF. The use of Quality-Adjusted Life Years in cost-effectiveness analyses in palliative care: mapping the debate through an integrative review. Palliat Med 2017; 31: 306–322.
6. Barton MB, Jacob SA, Gebsky V., Utility-adjusted analysis of the cost of palliative radiotherapy for bone metastases. Australas Radiol 2003; 47: 274–278.
7. Albers G, Echteld MA, de Vet HC. Evaluation of quality-of-life measures for use in palliative care: a systematic review. Palliat Med 2010; 24: 17–37.
8. Hearn J, Higginson IJ., Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Qual Health Care 1999; 8: 219–227.
9. Bausewein C, Booth S, Gysels M. Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med 2010; 13: 1109–1118.
10. Goodwin DM, Higginson IJ, Myers K. Effectiveness of palliative day care in improving pain, symptom control, and quality of life. J Pain Symptom Manage 2003; 25: 202–212.
11. Hall S, Petkova H, Tsouros AD. Palliative care for older people: better practices. 2011, World Health Organization Europe, http://www.euro.who.int/en/publications/abstracts/palliative-care-for-older-people-better-practices
12. Brazier JE, Yang Y, Tsuchiya A. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ 2010; 11: 215–225.
13. Buxton MJ, Lacey LA, Feagan BG. Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn’s Disease Activity Index in Crohn’s disease and measures of utility. Value Health 2007; 10: 214–220.
14. Brooks R., EuroQol: the current state of play. Health Policy 1996; 37: 53–72.
15. Dolan P., Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095–1108.
16. Siegert RJ, Gao W, Walkey FH. Psychological well-being and quality of care: a factor-analytic examination of the palliative care outcome scale. J Pain Symptom Manage 2010; 40: 67–74.
17. Gomes B, McCrone P, Hall S. Variations in the quality and costs of end-of-life care, preferences and palliative outcomes for cancer patients by place of death: the QUALYCARE study. BMC Cancer 2010; 10: 400.
18. Higginson IJ, Gao W, Saleem TZ. Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factors. PLoS ONE 2012; 7: e46327.
19. Johnson RA, Wichern DW., Applied multivariate statistical analysis. 4th ed. Upper Saddle River, NJ: Prentice-Hall, Inc., 1988.
20. Kaiser HF., The application of electronic computers to factor analysis. Educ Psychol Meas 1960; 20: 141–151.
21. Horn J., A rationale and test for the number of factors in factor analysis. Psychometrika 1965; 30: 179–185.
22. Watkins M., A standalone Windows program that computes Parallel Analysis criteria (eigenvalues) by performing a Monte Carlo simulation. 2002, http://edpsychassociates.com/Watkins3.html (accessed 9 June 2016).
23. Nunnally JC., Psychometric theory. 2nd ed. New York: McGraw-Hill, Inc., 1978.
24. Tabachnick BG, Fidell L., Using multivariate statistics. 4th ed. Needham Heights, MA: Allyn & Bacon, 2001.
25. Powell JL., Least absolute deviations estimation for the censored regression model. J Economet 1984; 25: 303–325.
26. Gray AM, Rivero-Arias O, Clarke PM., Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Med Decis Making 2006; 26: 18–29.
27. Rivero-Arias O, Ouellet M, Gray A. Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Making 2010; 30: 341–354.
28. Longworth L, Yang Y, Young T. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess 2014; 18: 1–224.
29. Teckle P, McTaggart-Cowan H, Van der Hoek K. Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D. Health Qual Life Outcomes 2013; 11: 203.
30. Walters SJ, Brazier JE., Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005; 14: 1523–1532.
31. Young TA, Mukuria C, Rowen D. Mapping functions in health-related quality of life: mapping from two cancer-specific health-related quality-of-life instruments to EQ-5D-3L. Med Decis Making 2015; 35: 912–926.
32. Greenberg E, Parks RP., A predictive approach to model selection and multicollinearity. J Appl Econometrics 1997; 12: 67–75.
33. Shmueli G., To explain or to predict? Statistic Sci 2010; 25: 289–310.
34. Wu S, Harris TJ, McAuley KB., The use of simplified or misspecified models: linear case. Canad J Chem Eng 2007; 85: 386–398.
35. Diehr P, Yanez D, Ash A. Methods for analyzing health care utilization and costs. Ann Rev Public Health 1999; 20: 125–144.
36. Kilian R, Matschinger H, Loeffler W. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment. J Mental Health Policy Econ 2002; 5: 21–31.
37. Rowen D, Brazier J, Roberts J., Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? Health Qual Life Outcomes 2009; 7: 1–9.
38. Franks P, Lubetkin EI, Gold MR. Mapping the SF-12 to the EuroQol EQ-5D Index in a national US sample. Med Decis Making 2004; 24: 247–254.
39. Kim S-K, Kim S-H, Jo M-W. Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke. Health Qual Life Outcomes 2015; 13: 32.
40. Sullivan PW, Lawrence WF, Ghushchyan V., A national catalog of preference-based scores for chronic conditions in the United States. Med Care 2005; 43: 736–749.
41. Pickard AS, Neary MP, Cella D., Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 2007; 5: 70.
42. Murtagh FEM, Groeneveld EI, Kaloki YE. Capturing activity, costs, and outcomes: the challenges to be overcome for successful economic evaluation in palliative care. Prog Palliat Care 2013; 21: 232–235.
43. Round J., Care at the end of life: an economic perspective. 1st ed. Cham: Springer International Publishing, 2016.
44. Coast J., Strategies for the economic evaluation of end-of-life care: making a case for the capability approach. Expert Rev Pharmacoecon Outcomes Res 2014; 14: 473–482.
45. Normand C., Measuring outcomes in palliative care: limitations of QALYs and the road to PalYs. J Pain Symptom Manage 2009; 38: 27–31.